| CAS NO: | 1417318-27-4 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 生物活性 | Utomilumab (PF 05082566) is a fully humanIgG2mAb agonist of the T-cell costimulatory receptor4-1BB/CD137. Utomilumab can be used for the research of relapsed/refractory follicular lymphoma (FL) and otherCD20+non-Hodgkin lymphomas (NHL)[1][2]. | |
| IC50& Target |
| |
| Clinical Trial | ||
| 分子量 | 388.42 | |
| 性状 | Liquid | |
| Formula | C17H24N8O3 | |
| CAS 号 | 1417318-27-4 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
